http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102468876-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02E10-549 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H10K10-484 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H10K85-657 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H10K85-111 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D517-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D517-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 |
| filingDate | 2017-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102468876-B1 |
| titleOfInvention | Naphthobischalcogenadiazole derivatives and methods for their preparation |
| abstract | An object of the present invention is to provide a naphthobischalcogenadiazole derivative that can be used as an intermediate for producing a fluorine atom-introduced naphthobischalcogenadiazole compound. The naphthobischalcogenadiazole derivatives of the present invention are of the formula (I): (Wherein, A 1 and A 2 are each independently an oxygen atom, a sulfur atom, a selenium atom or a tellurium atom; X 1 and X 2 are each independently a hydrogen atom, a halogen atom, a boronic acid group, a boronic acid ester group, boronic acid diamino naphthalenamide group, boronic acid N-methyliminodiacetic acid ester group, trifluoroborate base or triol borate base). |
| priorityDate | 2016-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 242.